A nanoscale drug delivery carrier using nucleic acid aptamers for extended release of therapeutic

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 8, Issue 7, 2012, Pages 1143-1151

  Sundaram, Padma ^a,b   Wower, Jacek ^b   Byrne, Mark E ^a  

^a AUBURN UNIVERSITY   (United States)

^b AUBURN UNIVERSITY   (United States)

Author keywords

DNA aptamer; Drug carrier; Extended drug release; Gold nanoparticles; Neomycin

Indexed keywords

APTAMERS; DRUG CARRIER; DRUG RELEASE; GOLD NANOPARTICLES; NEOMYCIN;

ANTIBIOTICS; BIOMOLECULES; DRUG DELIVERY; METAL NANOPARTICLES; SODIUM CHLORIDE;

DNA;

GOLD NANOPARTICLE; NEOMYCIN; NUCLEIC ACID; SINGLE STRANDED DNA;

ARTICLE; BINDING AFFINITY; CONTROLLED DRUG RELEASE; DNA DRUG COMPLEX; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DNA BINDING; MOLECULAR BIOLOGY; NANOTECHNOLOGY; TEMPERATURE;

ANTI-BACTERIAL AGENTS; APTAMERS, NUCLEOTIDE; BINDING SITES; DELAYED-ACTION PREPARATIONS; GOLD; NANOPARTICLES; NEOMYCIN;

EID: 84866480382     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2012.01.010     Document Type: Article

References (50)

1. Turek C., Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990, 249:505-510.
2. Wilson D.S., Szostak J.W. In vitro selection of functional nucleic acids. Annu Rev Biochem 1999, 68:611-647.
3. Cho E.J., Collett J.R., Szafranska A.E., Ellington A.D. Optimization of aptamer microarray technology for multiple protein targets. Anal Chim Acta 2006, 564:82-90.
4. Hermann T., Patel D.J. Adaptive recognition by nucleic acid aptamers. Science 2000, 287:820-825.
5. Famulok M. Oligonucleotide aptamer that recognizes small molecules. Curr Opin Struct Biol 1999, 9:324-329.
6. Wang Y., Rando R.R. Specific binding of aminoglycoside antibiotics to RNA. Chem Biol 1995, 2(5):281-290.
7. Wallis M.G., Ahsen U.V., Schroeder R., Famulok M. A novel RNA motif for neomycin recognition. Chem Biol 1995, 2(8):543-552.
8. Biroccio A., Hamm J., Incitti I., Francesco R.D., Tomei L. Selection of RNA aptamer that are specific and high affinity ligands of hepatitis c virus RNA dependent RNA-polymerase. J Virol 2002, 76(8):3688-3696.
9. Gopinath S.C.B., Misono T.S., Kawazaki K., Mizuno T., Imai M., Odagiri T., Kumar P.K.R. A RNA aptamer that distinguishes between closely related human influenza viruses and inhibits haemagglutinin-mediated membrane fusion. J Gen Virol 2006, 87:479-487.
10. Ng E.W.N., Shima D.T., Cunningham E.T., Guyer D.R., Adamis A.P. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nature Revs Drug Disc 2006, 5:123-132.
11. Clinical trial.gov, National Institute of Health (NIH) (Accessed April 4, 2011). http://www.clinicaltrials.gov/ct2/results?term=Aptamer+drugs.
12. Aurup H., Williams D.M., Eckstein F. 2'-fluoro- and 2'-amino-2'-deoxynucleoside 5'-triphosphates as substrates for T7 RNA polymerase. Biochemistry 1992, 31:9636-9641.
13. Nabel G.J., Nabel E.G., Yang Z.Y., Fox B.A., Plautz G.E., Gao X., et al. Direct gene transfer with DNA-liposome complexes in melanoma: expression biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci 1993, 90:11307-11311.
14. Venkatesh S, Wower J, Byrne ME. Drug delivery systems and methods.US 2008/0138408 A1, June 12, 2008.
15. Venkatesh S., Wower J., Byrne M.E. Nucleic acid therapeutic carriers with on-demand triggered release. Bioconjug Chem 2009, 20:1773-1782.
16. Isenberg S.J., Apt L., Valenton M., Signore M.L., Cubillan L., Labrador M.A., et al. A controlled trial of povidone-iodine to treat infectious conjunctivitis in children. Am J Ophthalmol 2002, 134(5):681-688.
17. Block S.L., Hedrick J., Tyler R., Smith A., Findlay R., Keegan E., Stroman D.W. Increasing bacterial resistance in pediatric acute conjunctivitis (1997-1998). Antimicrob Agents Chemother 2000, 44(6):1650-1654.
18. Yusifov T.N., Abduragimov A.R., Narsinh K., Gasymov O.K., Glasgow B.J. Tear lipocalin is the major endonuclease in tears. Mol Vis 2008, 14:180-188.
19. Yang H., Liu H., Kang H., Tan W. Engineering target-responsive hydrogels based on aptamer-target interactions. J Am Chem Soc 2008, 130:6320-6321.
20. Soontornworajit B., Zhou J., Zhang Z., Wang Y. Aptamer-functionalized in situ injectable hydrogel for controlled protein release. Biomacromolecules 2010, 11:2724-2730.
21. Soontornworajit B., Zhou J., Zhang Z., Wang Y. A hybrid particle-hydrogel composite for oligonucleotide-mediated pulsatile protein release. Soft Matter 2010, 6:4255-4261.
22. Yoon T.J., Kim J.S., Kim B.G., Yu K.N., Cho M.H., Lee J.K. Multifunctional nanoparticles possessing a "magnetic motor effect" for drug or gene delivery. Angew Chem 2005, 117:1092-1095.
23. Panyam J., Zhou W.Z., Prabha S., Sahoo S.K., Labhasetwar V. Rapid endo-lysosomal escape of poly(dl-lactide-coglycolide)nanoparticles: implications for drug and gene delivery. The FASEB Journal 2002, 16:1217-1226.
24. Davis M.E., Zuckerman J.E., Choi C.H.J., Seligson D., Tolcher A., Alabi C.A., et al. Evidence of RNAi in humans from systemically administered sirna via targeted nanoparticles. Nature 2010, 464:1067-1071.
25. Connor E.E., Mwamuka J., Gole A., Murphy C.J., Wyatt M.D. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 2005, 1(3):325-327.
26. Shukla R., Bansal V., Chaudhary M., Basu A., Bhonde R.R., Sastry M. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir 2005, 21:10644-10654.
27. Chithrani D.B., Chan W.C.W. Elucidating the mechaninism of cellular uptake and removal of protein coated gold nanoparticle of different sizes and shapes. Nano Lett 2007, 7(6):1542-1550.
28. Chithrani D.B., Ghazani A.A., Chan W.C.W. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 2006, 6(4):662-668.
29. Rosi N.L., Giljohann D.A., Thaxton C.S., Lytton-Jean A.K.R., Han M.S., Mirkin C.A. Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 2006, 312(5776):1027-1030.
30. Pan C.Q., Lazarus R.A. Engineering hyperactive variants of human deoxyribonuclease I by altering its functional mechanism. Biochemistry 1997, 36(22):6624-6632.
31. Giljohann D.A., Seferos D.S., Daniel W.L., Massich M.D., Patel P.C., Mirkin C.A. Gold nanoparticle for biology and medicine. Angew Chem Int Ed 2010, 49:3280-3294.
32. Giljohann D.A., Seferos D.S., Patel P.C., Millstone J.E., Mirkin C.A. Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticles. Nano Lett 2007, 7:3818-3821.
33. Giljohann D.A., Seferos D.S., Prigodich A.E., Patel P.C., Mirkin C.A. Gene regulation with polyvalent siRNA-nanoparticle conjugates. J Am Chem Soc 2009, 131:2072-2073.
34. Martha F.J., Olke U.C. Substrate sequence effect on hammerhead RNA catalytic efficiency. Proc Natl Acad Sci 1990, 87:1668-1672.
35. Hurst S.J., Lytton-Jean A.K.R., Mirkin C.A. Maximizing DNA loading on a range of gold nanoparticle sizes. Anal Chem 2006, 78:8313-8318.
36. Hill H.D., Millstone J.E., Banholzer M.J., Mirkin C.A. The role radius of curvature plays in thiolated oligonucleotide loading on gold nanoparticles. ACS Nano 2009, 3:418-424.
37. Parak W.J., Pellegrino T., Micheel C.M., Gerion D., Williams S.C., Alivisatos P.A. Conformation of oligonucleotides attached to gold nanocrystals probed by gel electrophoresis. Nano Lett 2003, 3:33-36.
38. Jenning T.L., Singh M.P., Strouse G.F. Fluorescent lifetime quenching near d = 1.5 nm gold nanoparticles: probing nset validity. J Am Chem Soc 2006, 128:5462-5467.
39. Moazed D., Noller H.F. Interactions of antibiotics with functional sites in 16s ribosomal RNA. Nature 1987, 327:389-394.
40. Recht M.I., Fourmy D., Blanchard S.C., Dahlquist K.D., Puglisi J.D. RNA sequence determinants for aminoglycoside binding to an A-site rRNA model oligonucleotide. J Mol Biol 1996, 262:421-436.
41. Jiang L., Majumdar A., Hu W., Jaishree T.J., Xu W., Patel D.J. Saccharide-RNA recognition in a complex formed between neomycin B and an RNA aptamer. Structure 1997, 7:817-827.
42. Civit L., Fragoso A., O'Sullivan C.K. Thermal stability of diazonium derived and thiol-derived layers on gold for application in genosensors. Electrochem Commun 2010, 12:1045-1048.
43. Suda H.K., Petrovykh D.Y., Tarlov M.J., Whiteman L.J. Base-dependent competitive adsorption of single stranded DNA on gold. J Am Chem Soc 2003, 125:9014-9015.
44. Demers L.M., Ostblom M., Zhang H., Jank N.H., Leidberg B., Mirkin C.A. Thermal desorption behavior and binding properties of DNA bases and nucleosides on gold. J Am Chem Soc 2002, 124:11248-11249.
45. Storhoff J.J., Elghanian R., Mirkin C.A., Letsinger R.L. Sequence depended stability of DNA modified gold nanopartilces. Langmuir 2002, 18:6666-6670.
46. Hasan M., Bethell D., Burst M. The fate of sulfur-bound hydrogen on formation of self-assembled thiol monolayers on gold: 1 h NMR spectroscopic evidence from solutions of gold clusters. J. Am Chem Soc 2002, 124:1132-1133.
47. Nuzzo R.G., Zegarsi B.R., Dubois L.H. Fundamental studies of the chemisorption of organosulfur compounds on Au (111) implications for molecular self-assembly on gold surfaces. J Am Chem Soc 1987, 109:733-740.
48. Gronbeck H., Curioni A., Andreoni W. Thiols and disulfides on the Au(111) surface: the headgroup-gold interaction. J Am Chem Soc 2000, 122:3839-3842.
49. Shipway A.N., Lahav M., Gabia R., Willner I. Investigations into the electrostatically induced aggregation of Au nanoparticles. Langmiur 2000, 16:8789-8795.
50. Steel A.B., Levicky R.L., Herne T.M., Tarlov M.J. Immobilization of nucleic acids at solid surfaces: effect of oligonucleotide length on layer assembly. Biophys J 2002, 79:975-981.